Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at Pinnacle Surgery Center in Austin, Texas, by ...

Francis Medical today announced the first commercial procedure using its Vanquish water vapor ablation system.

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...

Mercy Medical Center is offering a new, noninvasive treatment option for men with localized prostate cancer using high-intensity focused ultrasound, also known ...

CEDAR RAPIDS, Iowa — Mercy Medical Center has introduced a new non-invasive treatment for men with localized prostate cancer ...

Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.

SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...

The 'game-changing' technology proved just as effective as MRI at diagnosing the disease but was cheaper and easier to use, researchers said. It could allow doctors to provide a 'one-stop shop' where ...

Market OverviewThe global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period.